Weiss Multi Strategy Advisers LLC Cyma Bay Therapeutics, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$1.33 - $5.93 $86,450 - $385,450	-65,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$6.05 - $13.66 $90,750 - $204,900	-15,000 Reduced 18.75%	65,000 $465,000
Q1 2019 May 15, 2019	BUY	$8.16 - $13.42 $146,880 - $241,560	18,000 Added 29.03%	80,000 $1.06 Million
Q4 2018 Feb 14, 2019	BUY	$6.54 - $11.74 $45,361 - $81,428	6,936 Added 12.6%	62,000 $488,000
Q3 2018 Nov 14, 2018	BUY	$10.88 - $14.52 $2,622 - $3,499	241 Added 0.44%	55,064 $610,000
Q2 2018 Aug 14, 2018	BUY	$10.66 - $14.38 $147,353 - $198,774	13,823 Added 33.71%	54,823 $736,000
Q1 2018 May 15, 2018	BUY	$9.0 - $15.16 $144,000 - $242,560	16,000 Added 64.0%	41,000 $533,000
Q4 2017 Feb 14, 2018	BUY	$7.67 - $9.31 $191,750 - $232,750	25,000	25,000 $230,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.